gliclazide has been researched along with copper sulfate in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Desfaits, AC; Renier, G; Serri, O | 1 |
1 other study(ies) available for gliclazide and copper sulfate
Article | Year |
---|---|
Gliclazide decreases cell-mediated low-density lipoprotein (LDL) oxidation and reduces monocyte adhesion to endothelial cells induced by oxidatively modified LDL.
Topics: Animals; Aorta; Cattle; Cell Adhesion; Cell Survival; Cells, Cultured; Copper Sulfate; Endothelium, Vascular; Gliclazide; Glyburide; Humans; In Vitro Techniques; Lipoproteins, LDL; Monocytes; Oxidation-Reduction; Thiobarbituric Acid Reactive Substances | 1997 |